John Weber Denninger, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mind-Body Therapies | 10 | 2020 | 247 | 1.770 |
Why?
|
| Resilience, Psychological | 7 | 2020 | 677 | 1.090 |
Why?
|
| Relaxation Therapy | 5 | 2018 | 178 | 0.920 |
Why?
|
| Burnout, Professional | 4 | 2019 | 694 | 0.820 |
Why?
|
| Internal Medicine | 3 | 2018 | 1009 | 0.810 |
Why?
|
| Relaxation | 6 | 2018 | 50 | 0.690 |
Why?
|
| Meditation | 4 | 2015 | 242 | 0.650 |
Why?
|
| Widowhood | 1 | 2017 | 54 | 0.610 |
Why?
|
| Psychiatry | 3 | 2018 | 1695 | 0.560 |
Why?
|
| Internship and Residency | 5 | 2021 | 5791 | 0.560 |
Why?
|
| Grief | 1 | 2017 | 248 | 0.520 |
Why?
|
| Social Behavior | 2 | 2011 | 1127 | 0.480 |
Why?
|
| Medicine | 1 | 2021 | 946 | 0.440 |
Why?
|
| Stress, Psychological | 10 | 2020 | 4245 | 0.440 |
Why?
|
| Depressive Disorder, Major | 11 | 2017 | 4639 | 0.410 |
Why?
|
| Adaptation, Psychological | 5 | 2020 | 2575 | 0.400 |
Why?
|
| Citalopram | 2 | 2011 | 403 | 0.390 |
Why?
|
| Psychotherapy, Group | 2 | 2014 | 406 | 0.380 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2015 | 445 | 0.350 |
Why?
|
| Students | 2 | 2020 | 1647 | 0.340 |
Why?
|
| Guanylate Cyclase | 2 | 2000 | 201 | 0.330 |
Why?
|
| Movement | 1 | 2015 | 1471 | 0.320 |
Why?
|
| Community Health Services | 1 | 2014 | 650 | 0.320 |
Why?
|
| Social Support | 2 | 2017 | 2118 | 0.320 |
Why?
|
| Curriculum | 2 | 2021 | 3605 | 0.320 |
Why?
|
| Fluoxetine | 3 | 2006 | 749 | 0.300 |
Why?
|
| Depression | 5 | 2018 | 7759 | 0.270 |
Why?
|
| Anxiety | 4 | 2019 | 4293 | 0.270 |
Why?
|
| Somatoform Disorders | 2 | 2006 | 423 | 0.270 |
Why?
|
| Physicians | 4 | 2019 | 4567 | 0.260 |
Why?
|
| Sleep | 2 | 2018 | 4622 | 0.230 |
Why?
|
| Interpersonal Relations | 1 | 2010 | 1425 | 0.220 |
Why?
|
| Models, Neurological | 1 | 2010 | 1775 | 0.210 |
Why?
|
| Pilot Projects | 10 | 2020 | 8319 | 0.200 |
Why?
|
| Tai Ji | 2 | 2017 | 285 | 0.200 |
Why?
|
| Program Development | 2 | 2020 | 1316 | 0.190 |
Why?
|
| Environment | 2 | 2020 | 1123 | 0.180 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2015 | 2428 | 0.180 |
Why?
|
| Antidepressive Agents | 1 | 2011 | 2838 | 0.170 |
Why?
|
| Social Isolation | 2 | 2012 | 365 | 0.170 |
Why?
|
| Yoga | 2 | 2013 | 253 | 0.170 |
Why?
|
| Indazoles | 1 | 2000 | 290 | 0.160 |
Why?
|
| Personnel, Hospital | 1 | 2020 | 283 | 0.160 |
Why?
|
| Psychotherapy | 2 | 2020 | 1642 | 0.160 |
Why?
|
| Cyclic GMP | 1 | 1999 | 409 | 0.150 |
Why?
|
| Cognition | 1 | 2015 | 6770 | 0.150 |
Why?
|
| Self Care | 3 | 2018 | 786 | 0.150 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 12073 | 0.150 |
Why?
|
| Education, Medical, Graduate | 2 | 2021 | 2291 | 0.150 |
Why?
|
| Videoconferencing | 1 | 2018 | 195 | 0.140 |
Why?
|
| Hospitals, General | 1 | 2020 | 749 | 0.140 |
Why?
|
| Veterans | 2 | 2020 | 2519 | 0.140 |
Why?
|
| Ambulatory Care | 2 | 2006 | 2708 | 0.140 |
Why?
|
| Social Adjustment | 2 | 2011 | 631 | 0.130 |
Why?
|
| Male | 35 | 2021 | 350115 | 0.130 |
Why?
|
| Job Satisfaction | 1 | 2019 | 534 | 0.130 |
Why?
|
| Morale | 1 | 2015 | 12 | 0.130 |
Why?
|
| Mind-Body Relations, Metaphysical | 1 | 2014 | 38 | 0.130 |
Why?
|
| Healthy People Programs | 1 | 2015 | 53 | 0.120 |
Why?
|
| Adult | 29 | 2020 | 214052 | 0.120 |
Why?
|
| Health Personnel | 2 | 2019 | 3219 | 0.120 |
Why?
|
| Female | 33 | 2021 | 380193 | 0.120 |
Why?
|
| Socioeconomic Factors | 2 | 2020 | 7785 | 0.110 |
Why?
|
| Humans | 44 | 2021 | 744366 | 0.110 |
Why?
|
| Workplace | 1 | 2019 | 836 | 0.110 |
Why?
|
| Focus Groups | 1 | 2017 | 1321 | 0.110 |
Why?
|
| Amygdala | 1 | 2020 | 1315 | 0.110 |
Why?
|
| Respiratory Tract Infections | 1 | 2020 | 961 | 0.110 |
Why?
|
| Group Processes | 1 | 2014 | 225 | 0.110 |
Why?
|
| Nitric Oxide | 2 | 2013 | 2132 | 0.110 |
Why?
|
| Middle Aged | 22 | 2020 | 213390 | 0.100 |
Why?
|
| Occupational Health | 1 | 2018 | 808 | 0.100 |
Why?
|
| Feasibility Studies | 4 | 2015 | 5077 | 0.100 |
Why?
|
| Frontal Lobe | 2 | 2009 | 1406 | 0.100 |
Why?
|
| Housing, Animal | 1 | 2011 | 48 | 0.100 |
Why?
|
| Sleep Deprivation | 1 | 2018 | 832 | 0.100 |
Why?
|
| Quality of Life | 6 | 2019 | 12802 | 0.100 |
Why?
|
| Self Efficacy | 1 | 2015 | 615 | 0.090 |
Why?
|
| Antidepressive Agents, Second-Generation | 2 | 2004 | 503 | 0.090 |
Why?
|
| Psychometrics | 3 | 2017 | 3003 | 0.090 |
Why?
|
| Military Personnel | 1 | 2019 | 1133 | 0.090 |
Why?
|
| Hydrocortisone | 2 | 2015 | 1826 | 0.090 |
Why?
|
| Academic Medical Centers | 2 | 2017 | 2760 | 0.090 |
Why?
|
| Program Evaluation | 2 | 2015 | 2488 | 0.090 |
Why?
|
| Health Resources | 1 | 2015 | 911 | 0.080 |
Why?
|
| Cyclohexanols | 1 | 2009 | 127 | 0.080 |
Why?
|
| Attitude | 1 | 2013 | 776 | 0.080 |
Why?
|
| Infertility, Female | 1 | 2014 | 788 | 0.080 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2017 | 6036 | 0.080 |
Why?
|
| Urban Population | 1 | 2015 | 2022 | 0.070 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2011 | 615 | 0.070 |
Why?
|
| Brain | 2 | 2010 | 26388 | 0.070 |
Why?
|
| Thalamus | 1 | 2012 | 1023 | 0.070 |
Why?
|
| Internet | 1 | 2018 | 3056 | 0.070 |
Why?
|
| Schools | 1 | 2015 | 1433 | 0.070 |
Why?
|
| Aged | 12 | 2020 | 163288 | 0.070 |
Why?
|
| Emotions | 1 | 2017 | 2659 | 0.070 |
Why?
|
| Chronic Disease | 3 | 2020 | 9145 | 0.070 |
Why?
|
| Child Behavior | 1 | 2011 | 839 | 0.070 |
Why?
|
| Quinolones | 1 | 2009 | 367 | 0.070 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2003 | 434 | 0.060 |
Why?
|
| Risk | 1 | 2016 | 9688 | 0.060 |
Why?
|
| Suicidal Ideation | 1 | 2013 | 1246 | 0.060 |
Why?
|
| Patient Care Team | 1 | 2015 | 2531 | 0.060 |
Why?
|
| Breast | 1 | 2013 | 1970 | 0.060 |
Why?
|
| Adolescent | 7 | 2015 | 85779 | 0.060 |
Why?
|
| Treatment Outcome | 11 | 2017 | 63107 | 0.060 |
Why?
|
| Health Promotion | 1 | 2015 | 2205 | 0.060 |
Why?
|
| Electroencephalography | 2 | 2009 | 6151 | 0.060 |
Why?
|
| Telemedicine | 1 | 2020 | 2872 | 0.060 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2014 | 3020 | 0.060 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2020 | 4266 | 0.050 |
Why?
|
| Patient-Centered Care | 1 | 2013 | 1438 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2018 | 8551 | 0.050 |
Why?
|
| Autistic Disorder | 1 | 2011 | 1185 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3135 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3242 | 0.050 |
Why?
|
| Overweight | 1 | 2013 | 2371 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2017 | 4687 | 0.050 |
Why?
|
| Inpatients | 1 | 2013 | 2518 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2013 | 2897 | 0.050 |
Why?
|
| Weight Loss | 1 | 2013 | 2625 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 3390 | 0.050 |
Why?
|
| Leukopoiesis | 1 | 2020 | 56 | 0.050 |
Why?
|
| Palliative Care | 1 | 2015 | 3493 | 0.050 |
Why?
|
| Wound Healing | 1 | 2011 | 2785 | 0.050 |
Why?
|
| Drug Resistance | 2 | 2003 | 1608 | 0.050 |
Why?
|
| Follow-Up Studies | 4 | 2015 | 39052 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8385 | 0.040 |
Why?
|
| Hippocampus | 1 | 2012 | 3675 | 0.040 |
Why?
|
| Suicide, Attempted | 1 | 2008 | 1218 | 0.040 |
Why?
|
| Time Factors | 2 | 2020 | 40075 | 0.040 |
Why?
|
| Young Adult | 5 | 2020 | 56429 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2018 | 53290 | 0.040 |
Why?
|
| Crime | 1 | 2020 | 215 | 0.040 |
Why?
|
| Free Radicals | 1 | 1999 | 237 | 0.040 |
Why?
|
| Insulin | 1 | 2013 | 6582 | 0.040 |
Why?
|
| Piperazines | 1 | 2009 | 2488 | 0.040 |
Why?
|
| Whole Body Imaging | 1 | 2020 | 280 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 25039 | 0.040 |
Why?
|
| Noise | 1 | 2020 | 279 | 0.040 |
Why?
|
| Hypertension | 1 | 2018 | 8479 | 0.040 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2000 | 247 | 0.040 |
Why?
|
| Catalysis | 1 | 1999 | 762 | 0.040 |
Why?
|
| Gene Regulatory Networks | 2 | 2018 | 1707 | 0.040 |
Why?
|
| Models, Chemical | 1 | 1999 | 626 | 0.040 |
Why?
|
| Brain Mapping | 1 | 2012 | 6670 | 0.040 |
Why?
|
| Africa South of the Sahara | 1 | 2019 | 724 | 0.040 |
Why?
|
| Vasculitis | 1 | 2020 | 519 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 1999 | 915 | 0.030 |
Why?
|
| Aging | 1 | 2015 | 8664 | 0.030 |
Why?
|
| Antipsychotic Agents | 1 | 2009 | 3057 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 57776 | 0.030 |
Why?
|
| Escherichia coli | 2 | 2000 | 4217 | 0.030 |
Why?
|
| Universities | 1 | 2020 | 951 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 15160 | 0.030 |
Why?
|
| Kinetics | 2 | 2000 | 6476 | 0.030 |
Why?
|
| Psychotic Disorders | 1 | 2009 | 3046 | 0.030 |
Why?
|
| Desipramine | 2 | 2004 | 184 | 0.030 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 1993 | 74 | 0.030 |
Why?
|
| Denmark | 1 | 2015 | 738 | 0.030 |
Why?
|
| Lithium Carbonate | 2 | 2004 | 184 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 1999 | 3130 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 2018 | 1180 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 13991 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 1999 | 3702 | 0.030 |
Why?
|
| Operon | 1 | 1993 | 363 | 0.030 |
Why?
|
| Dance Therapy | 1 | 2011 | 8 | 0.030 |
Why?
|
| Allostasis | 1 | 2013 | 70 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2014 | 465 | 0.030 |
Why?
|
| Leucine | 1 | 1993 | 560 | 0.030 |
Why?
|
| Saliva | 1 | 2015 | 809 | 0.020 |
Why?
|
| Income | 1 | 2020 | 1913 | 0.020 |
Why?
|
| Drug Therapy, Combination | 3 | 2009 | 6489 | 0.020 |
Why?
|
| Awareness | 1 | 2015 | 640 | 0.020 |
Why?
|
| Personality Inventory | 2 | 2004 | 1030 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 8300 | 0.020 |
Why?
|
| Demography | 1 | 2015 | 1655 | 0.020 |
Why?
|
| Fatigue | 1 | 2018 | 1531 | 0.020 |
Why?
|
| Music Therapy | 1 | 2011 | 102 | 0.020 |
Why?
|
| Antimanic Agents | 2 | 2004 | 522 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2020 | 77460 | 0.020 |
Why?
|
| Protein Binding | 2 | 2000 | 9384 | 0.020 |
Why?
|
| Religion | 1 | 2013 | 356 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2018 | 2682 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2008 | 1953 | 0.020 |
Why?
|
| Propensity Score | 1 | 2015 | 1781 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 15078 | 0.020 |
Why?
|
| Emigrants and Immigrants | 1 | 2014 | 522 | 0.020 |
Why?
|
| Immune System | 1 | 2013 | 806 | 0.020 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 1993 | 1122 | 0.020 |
Why?
|
| Self Report | 1 | 2018 | 3553 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2014 | 1782 | 0.020 |
Why?
|
| Animals | 5 | 2014 | 168768 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 2278 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 2726 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2887 | 0.020 |
Why?
|
| Checklist | 1 | 2014 | 833 | 0.020 |
Why?
|
| Social Environment | 1 | 2011 | 1022 | 0.020 |
Why?
|
| Gene Expression | 1 | 1999 | 7798 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2020 | 4232 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 20824 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2013 | 1403 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2020 | 23336 | 0.020 |
Why?
|
| Rats | 2 | 2012 | 24252 | 0.020 |
Why?
|
| Attention | 1 | 2015 | 2397 | 0.020 |
Why?
|
| Cell Line | 1 | 1999 | 16000 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3921 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 1888 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2018 | 40559 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2012 | 2016 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 10943 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 15535 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 9445 | 0.010 |
Why?
|
| Mental Health | 1 | 2015 | 3010 | 0.010 |
Why?
|
| Drug Therapy | 1 | 2004 | 497 | 0.010 |
Why?
|
| Patient Dropouts | 1 | 2003 | 420 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2008 | 2290 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 8642 | 0.010 |
Why?
|
| ROC Curve | 1 | 2008 | 3528 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2003 | 1005 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 1993 | 3854 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2012 | 3395 | 0.010 |
Why?
|
| Mitochondria | 1 | 2013 | 3514 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2004 | 12025 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2012 | 6994 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2014 | 10483 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2004 | 1828 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 6234 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1993 | 9647 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 9955 | 0.010 |
Why?
|
| Signal Transduction | 1 | 1999 | 23404 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 8949 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2004 | 2419 | 0.010 |
Why?
|
| Leucine-Responsive Regulatory Protein | 1 | 1993 | 2 | 0.010 |
Why?
|
| Transcription Factors | 1 | 1993 | 12207 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1993 | 878 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1993 | 574 | 0.010 |
Why?
|
| Obesity | 1 | 2013 | 12746 | 0.010 |
Why?
|
| DNA Primers | 1 | 1993 | 2891 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2011 | 41005 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 1993 | 1465 | 0.010 |
Why?
|
| Plasmids | 1 | 1993 | 2308 | 0.000 |
Why?
|
| Cloning, Molecular | 1 | 1993 | 4320 | 0.000 |
Why?
|
| Mice | 1 | 2014 | 81201 | 0.000 |
Why?
|
| Escherichia coli Proteins | 1 | 1993 | 1050 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 19905 | 0.000 |
Why?
|
| Prevalence | 1 | 2003 | 15221 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 35425 | 0.000 |
Why?
|
| United States | 1 | 2013 | 69872 | 0.000 |
Why?
|
| Child | 1 | 2011 | 77709 | 0.000 |
Why?
|
| Base Sequence | 1 | 1993 | 12797 | 0.000 |
Why?
|
| Promoter Regions, Genetic | 1 | 1993 | 5867 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1993 | 18111 | 0.000 |
Why?
|
| Transcription, Genetic | 1 | 1993 | 7721 | 0.000 |
Why?
|
| Risk Factors | 1 | 2003 | 72296 | 0.000 |
Why?
|